Vaccination documentation in the pharmacy

Since 2 July 2026, trained pharmacists in Germany may vaccinate adults with all vaccines that are not live vaccines; in practice, the new vaccinations start once the training courses for them are running. Every vaccination comes with four duties: nine items recorded in the pharmacy under Section 35a (5) of the Pharmacy Operating Regulations (ApBetrO), kept for ten years; the entry in the vaccination card (Impfausweis) or a vaccination certificate under Section 22 of the Infection Protection Act (IfSG), confirmed by the pharmacist personally; the transmission of pseudonymized data to the Robert Koch Institute and the Paul-Ehrlich-Institut under Section 13 (5) IfSG; and, if a vaccination complication is suspected, a report by the head of the pharmacy to the public health office without undue delay, if no physician has been called in – the report must reach the office within 24 hours of becoming aware.

Law as of October 2026

This page gives a carefully researched overview as of the date stated. It does not claim to be complete and does not replace legal advice; the legal situation may change. The legal texts and the requirements of the competent authorities and chambers are authoritative.

What changed on 2 July 2026

Pharmacies in Germany have vaccinated against influenza and COVID-19 for several years. With the Pharmacy Care Development Act (ApoVWG) of 26 June 2026, the legislature redrafted Section 20c of the Infection Protection Act; the change has applied since 2 July 2026. Since then, pharmacists may carry out vaccinations with all vaccines that are not live vaccines – provided they have completed physician-led training and their successful participation has been confirmed, they vaccinate for the community pharmacy whose staff they belong to, and the person to be vaccinated is at least 18 years old. The former exception for COVID-19 vaccinations from age twelve no longer applies.^{1, 2}

Delegation is also new. The administration of the vaccine – and only that – may be delegated by the pharmacist to pharmaceutical technical assistants (PTA), pharmacy engineers (Pharmazieingenieure, a German pharmacy qualification with no English equivalent) and pharmacy graduates in their practical training year who are not yet licensed, provided they have completed physician-led training and the pharmacist supervises them. Informing the patient, taking the medical history, obtaining consent and the vaccination documentation under Section 22 IfSG remain the pharmacist’s tasks.¹

Law and practice still diverge. Pharmacists who completed physician-led training for influenza or COVID-19 vaccinations under the previous rules may continue to give both without new training; for all other vaccines they need supplementary training. The Federal Chamber of Pharmacists adopted the model curriculum on 13 October 2026: 23 training units of 45 minutes for pharmacists not yet trained, 14 for the supplementary training – plus one more for those who want to vaccinate subcutaneously – and 8 for PTA. The courses are being planned; until then, pharmacies continue to vaccinate against influenza and COVID-19. The statutory health insurers currently pay pharmacies only for these two vaccinations; the German Pharmacists’ Association (DAV) and the National Association of Statutory Health Insurance Funds are negotiating the extension. The president of the Federal Chamber of Pharmacists expects all vaccinations with non-live vaccines to be reimbursable by the statutory health insurers from the start of 2027 at the latest.^{1, 12, 13}

For the pharmacy itself, Section 35a ApBetrO applies. The quality management system sets out preparation, informing the patient and consent, medical history and the decision when not to vaccinate, administration, documentation, hygiene and the reporting of suspected vaccination complications. Unless vaccinations are carried out exclusively at the person’s location (outreach vaccination), the pharmacy needs a suitable room, which must not be used for any other purpose during vaccination, with a waiting area. The head of the pharmacy needs business liability insurance covering damage caused by the vaccinations and notifies the competent authority of the vaccinations and the rooms intended for them at least one week before starting, as well as of later changes. Extending the range of vaccinations is likely to be such a change; if in doubt, the pharmacy clarifies this with the authority and the scope of cover with its insurer.^{3, 4, 11}

The duties at a glance

What has to be documented and reported for every vaccination, who does it and by when. The table gives the provisions in short form.

Who	What	Legal basis	Time limit
Vaccinating pharmacist – before vaccination	Informs the person orally (benefit and disease, side effects, complications and contraindications, behavior after vaccination, onset and duration of protection, boosters), takes the medical history including current condition and obtains consent. Cannot be delegated.	Section 35a (4) ApBetrO, Section 20c (4) sentence 2 IfSG, Sections 630d and 630e German Civil Code (BGB)^{3, 1, 10}	before every vaccination
Pharmacy – documentation	Records nine items: date and conduct of the information discussion and of the medical history, consent, date of vaccination, vaccine with batch, name, date of birth and address of the vaccinated person, name and address of the pharmacy, name and confirmation of the person who informed the patient, took the medical history and obtained consent, and of the person who vaccinated – if delegated, with the supervising pharmacist’s initials.	Section 35a (5) sentence 1 ApBetrO³	for every vaccination
Pharmacy – counseling without vaccination	If no vaccination follows the information discussion or medical history, the date of vaccination, the vaccine and the details of the vaccinating person are not required; the remaining items still have to be documented.	Section 35a (5) sentence 2 ApBetrO³	whenever a vaccination is not given
Vaccinating pharmacist – vaccination card	Enters the vaccination in the vaccination card, otherwise in a vaccination certificate: date, vaccine and batch, disease, name and date of birth of the person, name and address of the responsible person, confirmation by handwritten signature or by qualified electronic signature or qualified electronic seal. Plus notes on what to do in case of unusual vaccine reactions, on compensation claims and the offices where they can be made, and on follow-up and booster vaccinations with suggested dates. Cannot be delegated.	Section 22 IfSG, Section 20c (4) sentence 2 IfSG^{5, 1}	without undue delay
Pharmacy – vaccination surveillance	Transmits, insofar as the data are available, pseudonymized data on every vaccination to the Robert Koch Institute and the Paul-Ehrlich-Institut, including month and year of birth, sex, postal code, date of vaccination and an identifier of the vaccination; for COVID-19 additionally the batch, among other things.	Section 13 (5) IfSG^{6, 14}	at the intervals set by the RKI and the PEI; for the transmission route see below
Head of the pharmacy – vaccination complication	Reports a suspected health impairment going beyond the usual extent of a vaccine reaction, by name, to the public health office – if no physician has been called in.	Section 6 (1) sentence 1 no. 3, Section 8 (1) no. 6 and (2), Section 9 (3) IfSG^{7, 8}	without undue delay; must reach the public health office within 24 hours of becoming aware
Pharmacy – retention	Keeps the documentation, on paper or electronically, together with the medical history form and the consent form. If no vaccination is given, Section 35a sets no starting point for the period; for treatment records, the Civil Code refers to the end of treatment.	Section 35a (5) sentence 3, Section 22 (2) ApBetrO, Section 630f (3) BGB^{3, 9, 10, 11}	retention period: ten years from the date of vaccination
Head of the pharmacy – before starting and for changes	Notifies the competent authority of the vaccinations and – unless vaccinations are carried out exclusively as outreach vaccination – of the rooms intended for them, as well as of later changes, and maintains business liability insurance covering damage caused by the vaccinations.	Section 2 (3a) ApBetrO⁴	at least one week before starting or before the change

A vaccination in the pharmacy, step by step

Eight steps from preparation to retention. Informing the patient, taking the medical history and obtaining consent are reserved to the trained pharmacist.

Preparation: the person brings their vaccination card, the medical history and consent forms are ready, an information leaflet can be handed out beforehand. Pharmaceutical staff (as defined in Section 1a (2) ApBetrO) may assist with the preparation; they are trained for this, and the training is documented.³
Information discussion: the pharmacist informs the person orally – about benefit and disease, side effects, complications and contraindications, behavior after vaccination, onset and duration of protection and boosters. A leaflet complements the conversation but does not replace it.^{3, 10, 15}
Medical history: the pharmacist takes the medical history, including vaccination history and current condition, to rule out acute illness and allergies, and decides whether to vaccinate.^{1, 3}
Consent: the person consents. The law does not require written form, but it does require documentation; since informing the patient and consent must be proven in a dispute, the Federal Chamber of Pharmacists recommends documenting them in writing. The person receives copies of documents they have signed. Consent under data protection law is not required; the person is informed about the processing of their data with a data protection notice.^{10, 11, 15}
Administration: the pharmacist vaccinates personally or delegates the administration to trained PTA, pharmacy engineers or pharmacy graduates in their practical training year, and supervises them. The room is not used for any other purpose during vaccination.^{1, 3}
After vaccination: the Federal Chamber of Pharmacists recommends observing the person under supervision in the pharmacy for at least 15 minutes. A written emergency plan for acute vaccine reactions must be in place, and epinephrine for injection must be kept in stock; emergency measures are a mandatory part of the physician-led training.^{1, 11}
Documentation: the pharmacist enters the vaccination in the vaccination card or certificate without undue delay, confirms it and gives the required notes; then the pharmacist completes the documentation with the items under Section 35a (5) ApBetrO. Pharmaceutical staff may assist with this documentation under the Pharmacy Operating Regulations; the entry under Section 22 IfSG is made and confirmed by the pharmacist.^{3, 5, 15}
Transmission and retention: the data for the Robert Koch Institute and the Paul-Ehrlich-Institut are transmitted via the route in use or, where none is available, kept complete for later submission; the records are retained for ten years.^{3, 6, 14}

Two limits belong in every standard operating procedure. First, delegation: only the administration can be delegated. Pharmaceutical staff may assist with preparation and with the documentation under the Pharmacy Operating Regulations, but the vaccination documentation under Section 22 IfSG and the confirmation in the vaccination card remain with the pharmacist. Where exactly assistance ends is not defined by law; a clear, rather narrow rule in the quality management system provides certainty.^{1, 3, 15}

Second, the scope: pharmacies may only vaccinate adults and only with non-live vaccines. Where both live and non-live vaccines exist against a disease, as with some travel vaccinations, only the non-live vaccine can be given in the pharmacy.¹

What happens to the data: Robert Koch Institute, public health office, drug safety

For vaccination surveillance, vaccination providers transmit, insofar as the data are available to them, pseudonymized data to the Robert Koch Institute and to the Paul-Ehrlich-Institut, at the intervals these set; the RKI evaluates them for vaccination surveillance, the PEI for drug safety. The data comprise a patient pseudonym, month and year of birth, sex, the five-digit postal code and district of the vaccinated person, the district of the vaccination provider, the date of vaccination, an antigen-specific documentation number and an ICD-coded diagnosis; for COVID-19 additionally the batch, indication and position in the vaccination series, among other things. Re-identification of the person must be ruled out. The duty also applies to pharmacies, for all vaccinations given there, not only against influenza and COVID-19.^{6, 14}

Information on the transmission route is inconsistent. The guideline of the Federal Chamber of Pharmacists (revision of 29 September 2026) provides for transmission to the RKI via the German Electronic Reporting and Information System for Infection Protection (DEMIS) and names the GEDISA portal, which generates the report once the vaccination data are entered. The gematik, by contrast, states in its DEMIS knowledge base (as of May 2026) that there is no interface for pharmacies yet; this is expected to become possible in 2027, and until then vaccination data are to be archived and submitted later. Pharmacies should ask their regional chamber of pharmacists (Landesapothekerkammer) for the current status and in any case keep the data so that they can be submitted completely later.^{11, 14}

A suspected vaccination complication – a health impairment going beyond the usual extent of a vaccine reaction – must be reported by name, without undue delay, to the public health office for the district where the person is currently staying or last stayed; the report must reach the office no later than 24 hours after the head of the pharmacy becomes aware of it. The duty lies with the head of the pharmacy, and only if no physician has been called in. The report contains the vaccination details under Section 22 IfSG; the Paul-Ehrlich-Institut provides a report form. The public health office forwards the report without undue delay via the competent authority of the federal state (Land) to the Paul-Ehrlich-Institut, with the initials, date of birth and sex instead of the name.^{7, 8, 16}

Separately, the pharmacist reports suspected adverse reactions to the Drug Commission of German Pharmacists (AMK) in line with professional rules. For vaccines, the batch designation is particularly important – one more reason to record it accurately for every vaccination.^{11, 16}

Paper, form or software

The Federal Chamber of Pharmacists provides forms with its guideline – consent and medical history, documentation, vaccination certificate and data protection notice, last revised on 29 September 2026; the commentary on the guideline is still the 2025 version. The documentation form is to be kept on paper or electronically for ten years together with the medical history form and the consent form.¹¹

Electronic documentation is permitted: records under the Pharmacy Operating Regulations may be kept on image or data carriers if they remain available throughout the retention period and can be made readable within a reasonable time. The original content of an entry must not be made illegible; under the Pharmacy Operating Regulations, changes must show whether they were made at the time of the original entry or later, and under the Civil Code also when. Where records are kept exclusively electronically, initials are replaced by an electronic signature and, since 22 September 2026, a handwritten signature by an advanced electronic signature. For the vaccination card and certificate, the Infection Protection Act applies: confirmation by handwritten signature or by qualified electronic signature or qualified electronic seal.^{9, 10, 5}

Many pharmacies have the medical history and consent forms signed on paper and store a scan in their software. The Pharmacy Operating Regulations permit records to be kept on image or data carriers. Whether the paper of signed forms may be destroyed after scanning, however, is not expressly regulated – there is neither a permission nor a prohibition. The evidential position should be considered: in a dispute, informing the patient and consent must be proven. As a signed private document, a declaration constitutes full proof that it was made; a scan is freely assessed by the court. Technical Guideline TR-RESISCAN of the Federal Office for Information Security (BSI) serves as orientation for an orderly scanning procedure. Whether the paper is destroyed afterwards is the pharmacy’s decision.^{9, 10, 18, 17}

How pharmacies recognize sound vaccination documentation

All items required by Section 35a (5) ApBetrO in one case file, checked for completeness before confirmation – for counseling without vaccination, without date of vaccination, vaccine and details of the vaccinating person.
Delegation reflected: who administered, whether under supervision and with which supervisor’s initials – without a silent default.
Vaccination card or certificate with the details and notes under Section 22 (2) to (4) IfSG, printable for signature.
Documents attached to the case file: signed medical history and consent forms filed where they belong, with evidence of when and by whom.
Traceable changes: nothing is overwritten after completion; corrections keep the original content recognizable.
Data for the Robert Koch Institute and the Paul-Ehrlich-Institut kept complete and exportable, so that they can be transmitted or submitted later.
Vaccination complications recorded with the time of reporting – reported without undue delay, and the report must reach the public health office within 24 hours of becoming aware.
Ten years of availability, as required; also recommended are encrypted storage, servers in Germany and role-based permissions.

How ScanDoc handles vaccination documentation

Since 12 October 2026, smart medication ScanDoc has included vaccination documentation for pharmacies in Germany. It records a vaccination in one case file – counseling, medical history, consent, vaccination, documents, vaccination certificate and RKI data set – even when counseling and vaccination take place on different days. ScanDoc checks the mandatory details under Section 35a (5) ApBetrO for completeness and plausibility before confirmation, explicitly asks about supervision when administration is delegated and locks the case file after completion; every change is logged.

ScanDoc prints the medical history and consent forms pre-filled, the signed scans are attached to the case file, and the vaccination certificate under Section 22 IfSG is produced as a PDF for signature. ScanDoc provides the data under Section 13 (5) IfSG as a CSV file; the pharmacy can complete or adjust it and transmit it, or submit it later, via the route provided by the RKI. Every export remains in a history. The data are stored encrypted in an ISO 27001-certified data center in Germany. The user interface is in German. ScanDoc supports this; responsibility for the documentation remains with the pharmacy. To get to know the vaccination documentation, please use the contact page.

Frequently asked questions from pharmacies

Which vaccinations may German pharmacies offer since July 2026?

Legally, all vaccinations with vaccines that are not live vaccines, for people aged 18 and over (Section 20c IfSG). The pharmacist needs physician-led training under the new curriculum or, if trained under the previous rules for influenza or COVID-19 vaccinations, supplementary training. The Federal Chamber of Pharmacists adopted the curriculum on 13 October 2026; until the courses run, pharmacies continue to vaccinate against influenza and COVID-19.

May a PTA vaccinate?

A PTA may administer the vaccine if the pharmacist delegates this, the PTA has completed physician-led training and the pharmacist supervises. Informing the patient, taking the medical history, obtaining consent and the vaccination documentation cannot be delegated. The same applies to pharmacy engineers and to pharmacy graduates in their practical training year. The model curriculum provides 8 training units of 45 minutes for PTA.

Does consent have to be given in writing?

No, the law does not require written form, but consent must be documented. Since it must be proven in a dispute that the patient was informed and consent was obtained (Section 630h (2) German Civil Code), the Federal Chamber of Pharmacists recommends documenting consent in writing. The person receives a copy of the documents they have signed.

What has to be documented if no vaccination follows the counseling?

The information discussion and the medical history with dates, consent where given, the details of the person and the pharmacy, and the name and confirmation of the pharmacist who counseled. The date of vaccination, the vaccine and the details of the vaccinating person are not required (Section 35a (5) sentence 2 ApBetrO). It is useful to record the reason, such as an acute illness.

How long must the documentation be kept?

Ten years from the date of vaccination (Section 35a (5) sentence 3 ApBetrO), together with the medical history form and the consent form. Under Section 630f (3) German Civil Code, treatment records are likewise kept for ten years, counted from the end of treatment; if no vaccination is given, Section 35a sets no starting point of its own. Electronic retention is permitted if the data remain available and readable throughout.

Who confirms the entry in the vaccination card?

The pharmacist responsible for the vaccination – if administration was delegated, the pharmacist who delegated and supervised. Confirmation is given by handwritten signature or by qualified electronic signature or qualified electronic seal (Section 22 (2) IfSG) and cannot be delegated to assistant staff.

How do vaccination data reach the Robert Koch Institute?

Pseudonymized, under Section 13 (5) IfSG – to the Robert Koch Institute and to the Paul-Ehrlich-Institut. The guideline of the Federal Chamber of Pharmacists (revision of 29 September 2026) provides for DEMIS and names the GEDISA portal; according to the gematik (as of May 2026) there is no DEMIS interface for pharmacies yet, it is expected in 2027, and until then the data are to be archived and submitted later. The regional chamber of pharmacists knows the current status.

Who reports a vaccination complication, and how quickly?

The head of the pharmacy, if no physician has been called in: by name and without undue delay to the public health office, where the report must arrive within 24 hours of becoming aware (Sections 6, 8 (1) no. 6, 9 (3) IfSG). The Paul-Ehrlich-Institut’s report form helps. Separately, a suspected adverse reaction is reported to the Drug Commission of German Pharmacists.

When will the statutory health insurers pay for the new vaccinations?

So far, they pay pharmacies only for influenza and COVID-19 vaccinations (contract under Section 132e (1a) of Book V of the Social Code, SGB V). The German Pharmacists’ Association and the National Association of Statutory Health Insurance Funds are negotiating the extension. The law had required, by 2 October 2026, a contract covering at least the non-live vaccinations recommended by the Standing Committee on Vaccination (STIKO); if it is not concluded, the arbitration board determines the content of the contract within one month. The president of the Federal Chamber of Pharmacists expects reimbursement from the start of 2027 at the latest.

Glossary

ApoVWG: Pharmacy Care Development Act of 26 June 2026 (Federal Law Gazette 2026 I No. 195). Redrafted Section 20c IfSG and amended, among others, Section 35a ApBetrO; largely in force since 2 July 2026.
IfSG: Infection Protection Act (Infektionsschutzgesetz). Section 20c governs pharmacists’ authority to vaccinate, Section 22 the vaccination card and certificate, Section 13 (5) vaccination surveillance, Sections 6, 8 and 9 the reporting of vaccination complications.
ApBetrO: Pharmacy Operating Regulations. Section 35a governs vaccinating in the pharmacy – quality management, staff, rooms, informing the patient, documentation, hygiene –, Section 2 (3a) notification and liability insurance, Section 22 the form of records.
Non-live vaccine: Vaccine containing no pathogens capable of replication (in German colloquially “Totimpfstoff”). Pharmacies may only administer such vaccines.
Supplementary training: Training for pharmacists trained under the previous rules for influenza or COVID-19 vaccinations; required for all other vaccines. The model curriculum of the Federal Chamber of Pharmacists provides 14 training units of 45 minutes, plus an optional one for subcutaneous vaccination.
Delegation: Transfer of the administration of the vaccine to trained PTA, pharmacy engineers or pharmacy graduates in their practical training year, under the pharmacist’s supervision (Section 20c (4) IfSG).
Initials (Namenszeichen): The supervising pharmacist’s initials in the documentation when administration was delegated. In purely electronic records, an electronic signature takes their place.
Vaccination card (Impfausweis), vaccination certificate: Proof of vaccination for the vaccinated person under Section 22 IfSG. The certificate is issued if no vaccination card is presented.
Vaccination surveillance: Monitoring of vaccination coverage and effects by the Robert Koch Institute on the basis of pseudonymized data (Section 13 (5) IfSG). The data also go to the Paul-Ehrlich-Institut; besides vaccination providers, the Associations of Statutory Health Insurance Physicians transmit data.
Patient pseudonym: Identifier under which a person’s vaccination data are transmitted; re-identification by the Robert Koch Institute or the Paul-Ehrlich-Institut must be ruled out.
DEMIS: German Electronic Reporting and Information System for Infection Protection; the intended route for transmitting vaccination data from pharmacies.
Vaccination complication: Health impairment going beyond the usual extent of a vaccine reaction. Even a suspicion must be reported to the public health office.
AMK: Drug Commission of German Pharmacists; receives reports on adverse reactions and other drug risks from pharmacies.
PEI: Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines; responsible for vaccine safety.
Replacement scanning: Digitizing paper documents with the aim of destroying the original. The Pharmacy Operating Regulations permit records on data carriers; whether signed forms may then be destroyed is not expressly regulated. The BSI guideline TR-RESISCAN describes an orderly procedure.

Sources

Section 20c Infection Protection Act as amended by the ApoVWG (authority, training, supplementary training, delegation, model curricula), German. www.gesetze-im-internet.de/ifsg/__20c.html, opens in a new tab
Pharmacy Care Development Act (ApoVWG) of 26 June 2026, Federal Law Gazette 2026 I No. 195; Article 7 (IfSG) and Article 3 (ApBetrO), in force on 2 July 2026, German. www.recht.bund.de/bgbl/1/2026/195/VO.html, opens in a new tab
Section 35a Pharmacy Operating Regulations (quality management, staff, rooms, informing the patient, documentation with nine items, ten-year retention), German. www.gesetze-im-internet.de/apobetro_1987/__35a.html, opens in a new tab
Section 2 (3a) Pharmacy Operating Regulations (business liability insurance, notification of vaccinations and rooms at least one week in advance, notification of changes), German. www.gesetze-im-internet.de/apobetro_1987/__2.html, opens in a new tab
Section 22 Infection Protection Act (vaccination card and certificate: details, confirmation, notes, follow-up and booster vaccinations), German. www.gesetze-im-internet.de/ifsg/__22.html, opens in a new tab
Section 13 (5) Infection Protection Act (vaccination surveillance: reporting bodies, recipients RKI and PEI, data fields, pseudonym), German. www.gesetze-im-internet.de/ifsg/__13.html, opens in a new tab
Section 6 (1) sentence 1 no. 3 and Section 8 Infection Protection Act (reportable suspected vaccination complication; duty of the head of the pharmacy, only if no physician has been called in), German. www.gesetze-im-internet.de/ifsg/__6.html, opens in a new tab · www.gesetze-im-internet.de/ifsg/__8.html, opens in a new tab
Section 9 (3) and (4) and Section 11 (4) Infection Protection Act (report without undue delay, arrival within 24 hours of becoming aware, competent public health office; forwarding via the state authority to the Paul-Ehrlich-Institut), German. www.gesetze-im-internet.de/ifsg/__9.html, opens in a new tab · www.gesetze-im-internet.de/ifsg/__11.html, opens in a new tab
Section 22 Pharmacy Operating Regulations (changes to entries, records on image and data carriers, electronic signature); Ordinance amending the Pharmacy Operating Regulations of 16 September 2026, Federal Law Gazette 2026 I No. 266 (advanced signature since 22 September 2026), German. www.gesetze-im-internet.de/apobetro_1987/__22.html, opens in a new tab · www.recht.bund.de/bgbl/1/2026/266/VO.html, opens in a new tab
Sections 630d to 630h German Civil Code (consent, informing the patient, documentation and retention, burden of proof), German. www.gesetze-im-internet.de/bgb/__630f.html, opens in a new tab · www.gesetze-im-internet.de/bgb/__630h.html, opens in a new tab
Federal Chamber of Pharmacists: guideline “Durchführung von Schutzimpfungen in öffentlichen Apotheken” (revision of 29 September 2026) with forms; commentary on the guideline (revision of 12 September 2025: observation period, emergency plan, epinephrine, reporting to the AMK), German. www.abda.de/fileadmin/user_upload/assets/Praktische_Hilfen/Leitlinien/Schutzimpfungen/LL_Schutzimpfungen_Apotheke.pdf, opens in a new tab · www.abda.de/fileadmin/user_upload/assets/Praktische_Hilfen/Leitlinien/Schutzimpfungen/LL_Schutzimpfungen_Apotheke_Kommentar.pdf, opens in a new tab
ABDA press release of 13 October 2026: “Bundesapothekerkammer schafft Grundlage für viele neue Impfungen in Apotheken” (model curriculum, implementation status, expected reimbursement); model curriculum of 13 October 2026, German. www.abda.de/aktuelles-und-presse/pressemitteilungen/detail/bundesapothekerkammer-schafft-grundlage-fuer-viele-neue-impfungen-in-apotheken/, opens in a new tab · www.abda.de/fileadmin/user_upload/assets/Fortbildung/Zertifikatfortbildungen__open_/Curriculum_Schutzimpfungen_in_Apo_26_10_13.pdf, opens in a new tab
ABDA: vaccinations in pharmacies (contract under Section 132e (1a) SGB V for influenza and COVID-19, negotiations on the extension); Section 132e SGB V, German. www.abda.de/fuer-apotheker/schutzimpfungen/schutzimpfungen-in-apotheken/, opens in a new tab · www.gesetze-im-internet.de/sgb_5/__132e.html, opens in a new tab
gematik, DEMIS knowledge base: “Meldung von Impfdaten über DEMIS” (as of May 2026) – no interface for pharmacies yet, expected in 2027, archive and submit later until then, German. wiki.gematik.de/spaces/DSKB/pages/676088951/Meldung+von+Impfdaten+%C3%BCber+DEMIS, opens in a new tab
Robert Koch Institute: FAQ on legal aspects, informing the patient and documentation in vaccination (a leaflet does not replace the conversation, consent without written form, confirmation cannot be delegated), German. www.rki.de/SharedDocs/FAQs/DE/Impfen/AllgFr_Rechtliches-Aufklaerung-Doku/FAQ-gesamt.html, opens in a new tab
Paul-Ehrlich-Institut: report forms, including the form for suspected vaccination complications under the IfSG; Drug Commission of German Pharmacists: report forms, German. www.pei.de/DE/arzneimittelsicherheit/pharmakovigilanz/meldeformulare-online-meldung/meldeformulare-online-meldung-node.html, opens in a new tab · www.abda.de/fuer-apotheker/arzneimittelkommission/amk/berichtsbogen-formulare/, opens in a new tab
Federal Office for Information Security (BSI): Technical Guideline TR-03138 “Replacement scanning” (TR-RESISCAN), advisory in nature, German. www.bsi.bund.de/DE/Themen/Unternehmen-und-Organisationen/Standards-und-Zertifizierung/Technische-Richtlinien/TR-nach-Thema-sortiert/tr03138/ersetzendes-scannentr-resiscan.html, opens in a new tab
Sections 416 and 371 Code of Civil Procedure (evidential value of signed private documents; electronic documents as evidence by inspection), German. www.gesetze-im-internet.de/zpo/__416.html, opens in a new tab · www.gesetze-im-internet.de/zpo/__371.html, opens in a new tab

Knowledge Vaccinating in the pharmacy: what must be documented